nikotor 10 mg
torrent pharma s.r.l. - nicorandilum - compr. - 10mg - terapia miocardului - vasodilatatoare alte vasodilatatoare utilizate in afectiuni cardiace
nikotor 20 mg
torrent pharma s.r.l. - nicorandilum - compr. - 20mg - terapia miocardului - vasodilatatoare alte vasodilatatoare utilizate in afectiuni cardiace
martifen 8,75 mg
lozy's pharmaceuticals s.l. - spania - flurbiprofenum - pastile - 8,75mg - medicamente pentru zona oro-faringiana medicamente pentru zona oro-faringiana
septazulen portocale 8,75 mg
infarmade s.l. - spania - flurbiprofenum - pastile - 8,75mg - medicamente pentru zona oro-faringiana medicamente pentru zona oro-faringiana
entecavir teva 0,5 mg
merckle gmbh - germania - entecavirum - compr. film. - 0,5mg - antivirale cu actiune directa inhib. nucleozidici si nucleotidici ai reverstranscriptazei
clopidogrel 1a pharma
acino pharma gmbh - clopidogrel - boli vasculare periferice - agenți antitrombotici - clopidogrelul este indicat la adulți pentru prevenirea evenimentelor aterotrombotice la:pacienții care suferă de infarct miocardic (de la câteva zile până la mai puțin de 35 zile), accident vascular cerebral ischemic (mai vechi de 7 zile până la mai puțin de 6 luni) sau boală arterială periferică dovedită. pacienții care suferă de sindrom coronarian acut:- non supradenivelare de segment st sindrom coronarian acut (angină pectorală instabilă sau fără undă q infarct miocardic), inclusiv pacienți supuși implantării de stent după intervenție coronariană percutanată în asociere cu acid acetilsalicilic (aas). supradenivelare de segment st infarct miocardic acut, în asociere cu aas în tratați medical, eligibili pentru tratamentul trombolitic. pentru informații suplimentare vă rugăm să consultați secțiunea 5.
clindamycin - mip 150 mg/ml
mip pharma gmbh - germania - clindamycinum - sol. inj./perf. - 150 mg/ml - macrolide, lincosamide si streptogramine lincosamide
clindamycin - mip 300 mg
chephasaar chem. - pharma fabrik gmbh - germania - clindamycinum - compr. film. - 300mg - macrolide, lincosamide si streptogramine lincosamide
clindamycin-mip 600 mg
chephasaar chem. - pharm. fabrik gmbh - germania - clindamycinum - compr. film. - 600mg - macrolide, lincosamide si streptogramine lincosamide
clopidogrel taw pharma (previously clopidogrel mylan)
taw pharma (ireland) limited - clopidogrel clorhidrat - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - agenți antitrombotici - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:, - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). , - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.